Fetal hypoxia and programming of matrix metalloproteinases
- 29 February 2012
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 17 (3-4), 124-134
- https://doi.org/10.1016/j.drudis.2011.09.011
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Angiotensin II receptors and drug discovery in cardiovascular diseaseDrug Discovery Today, 2011
- Foetal hypoxia increases cardiac AT2R expression and subsequent vulnerability to adult ischaemic injuryCardiovascular Research, 2010
- Foetal nicotine exposure causes PKCε gene repression by promoter methylation in rat heartsCardiovascular Research, 2010
- Physiology and pathophysiology of matrix metalloproteasesAmino Acids, 2010
- Microarray-based Transcriptional and Epigenetic Profiling of Matrix Metalloproteinases, Collagens, and Related Genes in CancerJournal of Biological Chemistry, 2010
- Cardiomyocyte enlargement, proliferation and maturation during chronic fetal anaemia in sheepExperimental Physiology, 2009
- Epigenetic Control of the Invasion-promoting MT1-MMP/MMP-2/TIMP-2 Axis in Cancer CellsPublished by Elsevier BV ,2009
- Transcriptional responses to intermittent hypoxiaRespiratory Physiology & Neurobiology, 2008
- Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavageThe Journal of cell biology, 2007
- Genomic DNA methylation: the mark and its mediatorsTrends in Biochemical Sciences, 2006